ANIP — ANI Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- $1.67bn
- $1.90bn
- $883.37m
Brief: Ani Pharmaceuticals Announces The FDA Approval Of Everolimus Tablets For Oral Suspension
Brief: Ani Pharmaceuticals Appoints Henry Gosebruch To Board Of Directors
U.S. RESEARCH ROUNDUP-Compass Minerals, Duke Energy, Tesla
ANI Pharmaceuticals, Inc. reports results for the quarter ended June 30 - Earnings Summary
ANI Pharmaceuticals Q2 adjusted EPS beats on increased volume in specialty areas
Brief: ANI Pharmaceuticals Q2 Adjusted EPS USD 2.21 Vs. IBES Estimate USD 2.05
U.S. RESEARCH ROUNDUP-IBM, MSCI, US Bancorp
Brief: Ani Pharmaceuticals Announces Intent To Appeal Rulings In CG Oncology Matter
U.S. STOCKS ON THE MOVE-SpaceX, Sandisk, Salesforce
U.S. STOCKS ON THE MOVE-SpaceX, Sandisk, Marvell Technology
U.S. STOCKS ON THE MOVE-American Express, Deckers, Q32 Bio
Corrected: BUZZ-ANI Pharma's eye implant meets main goals in eye disease trial
U.S. RESEARCH ROUNDUP-Airbnb, HII, Tesla
ANI Pharmaceuticals Q1 revenue rises 21%, adjusted EPS beats estimates
Brief: ANI Pharmaceuticals Q1 Adjusted EPS USD 2.05 Vs. IBES Estimate USD 1.3
U.S. STOCKS ON THE MOVE-Conagra, Oracle, Replimune
U.S. STOCKS ON THE MOVE-Allogene Therapeutics, Adobe, Williams-Sonoma
ANI Pharmaceuticals rises on US launch of generic epilepsy drug
U.S. STOCKS ON THE MOVE-Meta, Legence, Chegg